We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Immutep and GlaxoSmithKline Sign Licence Agreement for a Novel Therapeutic Antibody for the Treatment of Autoimmune Diseases

News   Jan 07, 2011

 
Immutep and GlaxoSmithKline Sign Licence Agreement for a Novel Therapeutic Antibody for the Treatment of Autoimmune Diseases
 
 
 

RELATED ARTICLES

Plant-based Diet Leads to Crohn’s Disease Remission, Says Case Study

News

Eating a plant-based diet may be an effective treatment for Crohn's disease, according to a case study published in the journal Nutrients.

READ MORE

Kitchen Sponges Host Bacteria-fighting Microbes

News

Kitchen sponges have been found to host viruses that infect bacteria, called bacteriophages. As the threat of antibiotic resistance increases, bacteriophages, or phages for short, may prove useful in fighting bacteria that cannot be killed by antibiotics alone,

READ MORE

Mystery Solved: Immunosuppressive Drug's Biosynthesis Revealed

News

Mycophenolic acid (MPA), discovered in 1893, was the first natural antibiotic to be isolated and crystallized in human history, however, the biogenesis of such an old and important molecule was an unsolved mystery for more than a century. Scientists have now cracked this intriguing black box by fully elucidating the biosynthetic pathway of MPA.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE